Solicitation of Nominations for Membership on the National Vaccine Advisory Committee, 71566-71567 [2011-29771]
Download as PDF
<![CDATA[
71566
Federal Register / Vol. 76, No. 223 / Friday, November 18, 2011 / Notices
supervisory responsibilities relating to
the subject matter of the order. Part V
ensures notification to the FTC of
changes in corporate status. Part VI
mandates that ScanScout submit reports
to the Commission detailing its
compliance with the order. Part VII
provides that the order expires after
twenty (20) years, with certain
exceptions.
The purpose of the analysis is to aid
public comment on the proposed order.
It is not intended to constitute an
official interpretation of the proposed
order or to modify its terms in any way.
By direction of the Commission.
Donald S. Clark,
Secretary.
[FR Doc. 2011–29792 Filed 11–17–11; 8:45 am]
BILLING CODE 6750–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Solicitation of Nominations for
Membership on the National Vaccine
Advisory Committee
Department of Health and
Human Services, Office of the Secretary,
Office of the Assistant Secretary for
Health.
ACTION: Notice.
AGENCY:
42 U.S.C. 300aa–5, Section
2105 of the Public Health Service (PHS)
Act, as amended. The Committee is
governed by the provisions of Public
Law 92–463, as amended (5 U.S.C.
Appendix 2), which sets forth standards
for the formation and use of advisory
committees.
SUMMARY: The National Vaccine
Program Office (NVPO), a program
office within the Office of the Assistant
Secretary for Health, Department of
Health and Human Services (HHS), is
soliciting nominations of qualified
candidates to be considered for
appointment as members to the National
Vaccine Advisory Committee (NVAC).
The activities of this Committee are
governed by the Federal Advisory
Committee Act (FACA). Management
support for the activities of this
Committee is the responsibility of the
NVPO.
Consistent with the National Vaccine
Plan, the Committee advises and makes
recommendations to the Assistant
Secretary for Health in his capacity as
the Director of the National Vaccine
Program, on matters related to the
Program’s responsibilities. Specifically,
the Committee studies and recommends
ways to encourage the availability of an
adequate supply of safe and effective
mstockstill on DSK4VPTVN1PROD with NOTICES
AUTHORITY:
VerDate Mar<15>2010
17:44 Nov 17, 2011
Jkt 226001
vaccination products in the United
States; recommends research priorities
and other measures to enhance the
safety and efficacy of vaccines. The
Committee also advises the Assistant
Secretary for Health in the
implementation of Sections 2102 and
2103 of the PHS Act; and identifies
annually the most important areas of
government and non-government
cooperation that should be considered
in implementing Sections 2102 and
2103 of the PHS Act.
DATES: All nominations for membership
on the Committee must be received no
later than 5 p.m. EDT on December 23,
2011, at the address listed below.
ADDRESSES: All nominations should be
mailed or delivered to: Bruce Gellin,
M.D., M.P.H., Executive Secretary,
NVAC, Office of the Assistant Secretary
for Health, Department of Health and
Human Services, 200 Independence
Avenue SW., Room 715–H, Hubert H.
Humphrey Building, Washington, DC
20201.
FOR FURTHER INFORMATION CONTACT: Mr.
´
Guillermo Aviles-Mendoza, J.D., LL.M.,
Public Health Advisor, National Vaccine
Program Office, Department of Health
and Human Services, 200 Independence
Avenue SW., Room 739G.4, Hubert H.
Humphrey Building, Washington, DC
20201; (202) 205–2982; or send an email
to nvpo@hhs.gov.
A copy of the Committee charter
which includes the Committee’s
structure and functions as well as a list
of the current membership can be
´
obtained by contacting Mr. AvilesMendoza or by accessing the NVAC
Web site at: www.hhs.gov/nvpo/nvac.
SUPPLEMENTARY INFORMATION: Committee
Function, Qualifications, and
Information Required: As part of an
ongoing effort to enhance deliberations
and discussions with the public on
vaccine and immunization policy,
nominations are being sought for
interested individuals to serve on the
Committee. Individuals selected for
appointment to the Committee will
serve as voting members. The NVAC
consists of 17 voting members. The
Committee is composed of 15 public
members, including the Chair, and two
representative members. Public
members shall be selected from
individuals who are engaged in vaccine
research or the manufacture of vaccines,
or who are physicians, members of
parent organizations concerned with
immunizations, representatives of state
or local health agencies or public health
organizations. Representative members
shall be selected from the vaccine
manufacturing industry who are
engaged in vaccine research or the
PO 00000
Frm 00057
Fmt 4703
Sfmt 4703
manufacture of vaccines. Individuals
selected for appointment to the
Committee can be invited to serve terms
of up to four years.
All NVAC members are authorized to
receive the prescribed per diem
allowance and reimbursement for travel
expenses that are incurred to attend
meetings and conduct authorized
Committee-related business, in
accordance with Standard Government
Travel Regulations. Individuals who are
appointed to serve as public members
are authorized also to receive
honorarium for attending Committee
meetings and to carry out other
authorized Committee-related business.
Individuals who are appointed to serve
as representative members for a
particular interest group or industry are
not authorized to receive honorarium
for the performance of these duties.
This announcement is to solicit
nominations of qualified candidates to
fill positions on the NVAC that are
scheduled to be vacated in the public
member category. The positions are
scheduled to be vacated during the
calendar year 2012.
Nominations
In accordance with the charter,
persons nominated for appointment as
members of the NVAC should be among
authorities knowledgeable in areas
related to vaccine safety, vaccine
effectiveness, and vaccine supply.
Nominations should be typewritten. The
following information should be
included in the package of material
submitted for each individual being
nominated for consideration: (1) A letter
of nomination that clearly states the
name and affiliation of the nominee, the
basis for the nomination (i.e., specific
attributes which qualify the nominee for
service in this capacity); and a statement
that the nominee is willing to serve as
a member of the Committee; (2) the
nominator’s name, address and daytime
telephone number, home and/or work
address, telephone number, and email
address; and (3) a current copy of the
nominee’s curriculum vitae.
Individuals can nominate themselves
for consideration of appointment to the
Committee. All nominations must
include the required information.
Incomplete nominations will not be
processed for consideration. The letter
from the nominator and certification of
the nominated individual must bear
original signatures; reproduced copies
of these signatures are not acceptable.
Applications cannot be submitted by
facsimile. The names of Federal
employees should not be nominated for
consideration of appointment to this
Committee. The Department makes
E:\FR\FM\18NON1.SGM
18NON1
Federal Register / Vol. 76, No. 223 / Friday, November 18, 2011 / Notices
every effort to ensure that the
membership of HHS Federal advisory
committees is fairly balanced in terms of
points of view represented and the
committee’s function. Every effort is
made that a broad representation of
geographic areas, gender, ethnic and
minority groups, and the disabled are
given consideration for membership on
HHS Federal advisory committees.
Appointment to this committee shall be
made without discrimination on the
basis of age, race, ethnicity, gender,
sexual orientation, disability, and
cultural, religious, or socioeconomic
status.
The Standards of Ethical Conduct for
Employees of the Executive Branch are
applicable to individuals who are
appointed as public members of Federal
advisory committees. Individuals
appointed to serve as public members of
Federal advisory committees are
classified as special Government
employees (SGEs). SGEs are
Government employees for purposes of
the conflict of interest laws. Therefore,
individuals appointed to serve as public
members of NVAC are subject to an
ethics review. The ethics review is
conducted to determine if the
individual has any interests and/or
activities in the private sector that may
conflict with performance of their
official duties as a member of the
Committee. Individuals appointed to
serve as public members of the
Committee will be required to disclose
information regarding financial
holdings, consultancies, and research
grants and/or contracts.
Bruce Gellin,
Deputy Assistant Secretary for Health,
Director, National Vaccine Program Office,
Executive Secretary, National Vaccine
Advisory Committee.
[FR Doc. 2011–29771 Filed 11–17–11; 8:45 am]
BILLING CODE 4150–44–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
mstockstill on DSK4VPTVN1PROD with NOTICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or Advisory
Board), National Institute for
Occupational Safety and Health
(NIOSH)
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), and pursuant to the
requirements of 42 CFR 83.15(a), the
Centers for Disease Control and
Prevention (CDC) announces the
VerDate Mar<15>2010
17:44 Nov 17, 2011
Jkt 226001
following meeting of the
aforementioned committee:
Board Public Meeting Times and
Dates: (All times are Eastern Time):
8:15 a.m.–5 p.m., December 7, 2011.
8:15 a.m.–4 p.m., December 8, 2011.
Public Comment Times and Dates (All
times are Eastern Time):
5 p.m.–6:30 p.m.,* December 7, 2011.
* Please note that the public comment
periods may end before the times
indicated, following the last call for
comments. Members of the public who
wish to provide public comments
should plan to attend public comment
sessions at the start times listed.
Place: Tampa Marriott Westshore,
1001 N. Westshore Blvd., Tampa,
Florida 33607; Phone: (800) 564–3489;
Fax: (813) 289–5464. Audio Conference
Call via FTS Conferencing. The USA
toll-free, dial-in number is 1–(866) 659–
0537 with a pass code of 9933701.
Status: Open to the public, limited
only by the space available. The meeting
space accommodates approximately 150
people.
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule, advice on
methods of dose reconstruction which
have also been promulgated by HHS as
a final rule, advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program, and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to the CDC.
NIOSH implements this responsibility
for CDC. The charter was issued on
August 3, 2001, renewed at appropriate
intervals, and will expire on August 3,
2013.
Purpose: This Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
PO 00000
Frm 00058
Fmt 4703
Sfmt 4703
71567
Secretary, HHS, advising the Secretary
on whether there is a class of employees
at any Department of Energy facility
who were exposed to radiation but for
whom it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class.
Matters To Be Discussed: The agenda
for the Advisory Board meeting
includes: NIOSH Program Update;
Department of Labor (DOL) Program
Update; Department of Energy (DOE)
Program Update; Mound Plant Work
Group Update; Pinellas Plant Site
Profile Update; SEC petitions for:
Weldon Spring, Hooker
Electrochemical, Linde Ceramics Plant,
Feed Materials Production Center
(Fernald, Ohio), General Steel
Industries; and Savannah River Site;
SEC Petition Status Updates;
Subcommittee and Work Group Reports;
and Board Work Sessions.
The agenda is subject to change as
priorities dictate.
In the event an individual cannot
attend, written comments may be
submitted in accordance with the
redaction policy provided below. Any
written comments received will be
provided at the meeting and should be
submitted to the contact person below
well in advance of the meeting.
Policy on Redaction of Board Meeting
Transcripts (Public Comment): (1) If a
person making a comment gives his or
her name, no attempt will be made to
redact that name. (2) NIOSH will take
reasonable steps to ensure that
individuals making public comment are
aware of the fact that their comments
(including their name, if provided) will
appear in a transcript of the meeting
posted on a public Web site. Such
reasonable steps include: (a) A
statement read at the start of each public
comment period stating that transcripts
will be posted and names of speakers
will not be redacted; (b) A printed copy
of the statement mentioned in (a) above
will be displayed on the table where
individuals sign up to make public
comments; (c) A statement such as
outlined in (a) above will also appear
with the agenda for a Board Meeting
when it is posted on the NIOSH Web
site; (d) A statement such as in (a) above
will appear in the Federal Register
Notice that announces Board and
Subcommittee meetings. (3) If an
individual in making a statement
reveals personal information (e.g.,
medical information) about themselves
that information will not usually be
redacted. The NIOSH FOIA coordinator
will, however, review such revelations
in accordance with the Freedom of
E:\FR\FM\18NON1.SGM
18NON1
]]>Agencies
[Federal Register Volume 76, Number 223 (Friday, November 18, 2011)]
[Notices]
[Pages 71566-71567]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-29771]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Solicitation of Nominations for Membership on the National
Vaccine Advisory Committee
AGENCY: Department of Health and Human Services, Office of the
Secretary, Office of the Assistant Secretary for Health.
ACTION: Notice.
-----------------------------------------------------------------------
AUTHORITY: 42 U.S.C. 300aa-5, Section 2105 of the Public Health Service
(PHS) Act, as amended. The Committee is governed by the provisions of
Public Law 92-463, as amended (5 U.S.C. Appendix 2), which sets forth
standards for the formation and use of advisory committees.
SUMMARY: The National Vaccine Program Office (NVPO), a program office
within the Office of the Assistant Secretary for Health, Department of
Health and Human Services (HHS), is soliciting nominations of qualified
candidates to be considered for appointment as members to the National
Vaccine Advisory Committee (NVAC). The activities of this Committee are
governed by the Federal Advisory Committee Act (FACA). Management
support for the activities of this Committee is the responsibility of
the NVPO.
Consistent with the National Vaccine Plan, the Committee advises
and makes recommendations to the Assistant Secretary for Health in his
capacity as the Director of the National Vaccine Program, on matters
related to the Program's responsibilities. Specifically, the Committee
studies and recommends ways to encourage the availability of an
adequate supply of safe and effective vaccination products in the
United States; recommends research priorities and other measures to
enhance the safety and efficacy of vaccines. The Committee also advises
the Assistant Secretary for Health in the implementation of Sections
2102 and 2103 of the PHS Act; and identifies annually the most
important areas of government and non-government cooperation that
should be considered in implementing Sections 2102 and 2103 of the PHS
Act.
DATES: All nominations for membership on the Committee must be received
no later than 5 p.m. EDT on December 23, 2011, at the address listed
below.
ADDRESSES: All nominations should be mailed or delivered to: Bruce
Gellin, M.D., M.P.H., Executive Secretary, NVAC, Office of the
Assistant Secretary for Health, Department of Health and Human
Services, 200 Independence Avenue SW., Room 715-H, Hubert H. Humphrey
Building, Washington, DC 20201.
FOR FURTHER INFORMATION CONTACT: Mr. Guillermo Avil[eacute]s-Mendoza,
J.D., LL.M., Public Health Advisor, National Vaccine Program Office,
Department of Health and Human Services, 200 Independence Avenue SW.,
Room 739G.4, Hubert H. Humphrey Building, Washington, DC 20201; (202)
205-2982; or send an email to nvpo@hhs.gov.
A copy of the Committee charter which includes the Committee's
structure and functions as well as a list of the current membership can
be obtained by contacting Mr. Avil[eacute]s-Mendoza or by accessing the
NVAC Web site at: www.hhs.gov/nvpo/nvac.
SUPPLEMENTARY INFORMATION: Committee Function, Qualifications, and
Information Required: As part of an ongoing effort to enhance
deliberations and discussions with the public on vaccine and
immunization policy, nominations are being sought for interested
individuals to serve on the Committee. Individuals selected for
appointment to the Committee will serve as voting members. The NVAC
consists of 17 voting members. The Committee is composed of 15 public
members, including the Chair, and two representative members. Public
members shall be selected from individuals who are engaged in vaccine
research or the manufacture of vaccines, or who are physicians, members
of parent organizations concerned with immunizations, representatives
of state or local health agencies or public health organizations.
Representative members shall be selected from the vaccine manufacturing
industry who are engaged in vaccine research or the manufacture of
vaccines. Individuals selected for appointment to the Committee can be
invited to serve terms of up to four years.
All NVAC members are authorized to receive the prescribed per diem
allowance and reimbursement for travel expenses that are incurred to
attend meetings and conduct authorized Committee-related business, in
accordance with Standard Government Travel Regulations. Individuals who
are appointed to serve as public members are authorized also to receive
honorarium for attending Committee meetings and to carry out other
authorized Committee-related business. Individuals who are appointed to
serve as representative members for a particular interest group or
industry are not authorized to receive honorarium for the performance
of these duties.
This announcement is to solicit nominations of qualified candidates
to fill positions on the NVAC that are scheduled to be vacated in the
public member category. The positions are scheduled to be vacated
during the calendar year 2012.
Nominations
In accordance with the charter, persons nominated for appointment
as members of the NVAC should be among authorities knowledgeable in
areas related to vaccine safety, vaccine effectiveness, and vaccine
supply. Nominations should be typewritten. The following information
should be included in the package of material submitted for each
individual being nominated for consideration: (1) A letter of
nomination that clearly states the name and affiliation of the nominee,
the basis for the nomination (i.e., specific attributes which qualify
the nominee for service in this capacity); and a statement that the
nominee is willing to serve as a member of the Committee; (2) the
nominator's name, address and daytime telephone number, home and/or
work address, telephone number, and email address; and (3) a current
copy of the nominee's curriculum vitae.
Individuals can nominate themselves for consideration of
appointment to the Committee. All nominations must include the required
information. Incomplete nominations will not be processed for
consideration. The letter from the nominator and certification of the
nominated individual must bear original signatures; reproduced copies
of these signatures are not acceptable. Applications cannot be
submitted by facsimile. The names of Federal employees should not be
nominated for consideration of appointment to this Committee. The
Department makes
[[Page 71567]]
every effort to ensure that the membership of HHS Federal advisory
committees is fairly balanced in terms of points of view represented
and the committee's function. Every effort is made that a broad
representation of geographic areas, gender, ethnic and minority groups,
and the disabled are given consideration for membership on HHS Federal
advisory committees. Appointment to this committee shall be made
without discrimination on the basis of age, race, ethnicity, gender,
sexual orientation, disability, and cultural, religious, or
socioeconomic status.
The Standards of Ethical Conduct for Employees of the Executive
Branch are applicable to individuals who are appointed as public
members of Federal advisory committees. Individuals appointed to serve
as public members of Federal advisory committees are classified as
special Government employees (SGEs). SGEs are Government employees for
purposes of the conflict of interest laws. Therefore, individuals
appointed to serve as public members of NVAC are subject to an ethics
review. The ethics review is conducted to determine if the individual
has any interests and/or activities in the private sector that may
conflict with performance of their official duties as a member of the
Committee. Individuals appointed to serve as public members of the
Committee will be required to disclose information regarding financial
holdings, consultancies, and research grants and/or contracts.
Bruce Gellin,
Deputy Assistant Secretary for Health, Director, National Vaccine
Program Office, Executive Secretary, National Vaccine Advisory
Committee.
[FR Doc. 2011-29771 Filed 11-17-11; 8:45 am]
BILLING CODE 4150-44-P
